Rallybio Corp. (RLYB) PT Lowered to $16 at JMP Securities
Tweet
Share
E-mailGet Alerts RLYB Hot Sheet
Price: $16.07 -0.99%
Rating Summary:
2 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
2 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
JMP Securities analyst Jonathan Wolleben lowered the price target on Rallybio Corp. (NASDAQ: RLYB) to $16.00 (from $26.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Medtronic, Inc. (MDT) PT Lowered to $101 at Needham
- BorgWarner (BWA) PT Raised to $95 at Wolfe Research, 'Bullish Takeaways from CEO Meetings'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
